Carl Zeiss Meditec Future Growth
Future criteria checks 3/6
Carl Zeiss Meditec is forecast to grow earnings and revenue by 16.3% and 7.9% per annum respectively. EPS is expected to grow by 16.7% per annum. Return on equity is forecast to be 11.9% in 3 years.
Key information
16.3%
Earnings growth rate
16.7%
EPS growth rate
Medical Equipment earnings growth | 22.6% |
Revenue growth rate | 7.9% |
Future return on equity | 11.9% |
Analyst coverage | Good |
Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2027 | 2,686 | 316 | 238 | N/A | 6 |
9/30/2026 | 2,455 | 256 | 248 | N/A | 13 |
9/30/2025 | 2,275 | 205 | 209 | N/A | 15 |
9/30/2024 | 2,073 | 162 | 176 | N/A | 15 |
6/30/2024 | 2,066 | 203 | N/A | N/A | N/A |
3/31/2024 | 2,062 | 261 | 122 | 263 | N/A |
12/31/2023 | 2,094 | 277 | N/A | N/A | N/A |
9/30/2023 | 2,089 | 290 | 137 | 251 | N/A |
6/30/2023 | 2,080 | 308 | N/A | N/A | N/A |
3/31/2023 | 2,022 | 278 | 63 | 162 | N/A |
12/31/2022 | 1,963 | 307 | N/A | N/A | N/A |
9/30/2022 | 1,903 | 294 | 106 | 188 | N/A |
6/30/2022 | 1,781 | 245 | N/A | N/A | N/A |
3/31/2022 | 1,735 | 264 | 207 | 285 | N/A |
12/31/2021 | 1,688 | 228 | N/A | N/A | N/A |
9/30/2021 | 1,647 | 236 | 297 | 363 | N/A |
6/30/2021 | 1,566 | 235 | N/A | N/A | N/A |
3/31/2021 | 1,388 | 159 | 240 | 290 | N/A |
12/31/2020 | 1,335 | 130 | N/A | N/A | N/A |
9/30/2020 | 1,335 | 122 | 134 | 179 | N/A |
6/30/2020 | 1,400 | 120 | N/A | N/A | N/A |
3/31/2020 | 1,507 | 166 | 132 | 171 | N/A |
12/31/2019 | 1,505 | 170 | N/A | N/A | N/A |
9/30/2019 | 1,459 | 160 | 173 | 220 | N/A |
6/30/2019 | 1,382 | 153 | N/A | N/A | N/A |
3/31/2019 | 1,334 | 129 | 195 | 242 | N/A |
12/31/2018 | 1,310 | 127 | N/A | N/A | N/A |
9/30/2018 | 1,281 | 126 | 152 | 187 | N/A |
6/30/2018 | 1,251 | 124 | N/A | N/A | N/A |
3/31/2018 | 1,216 | 129 | N/A | 56 | N/A |
12/31/2017 | 1,205 | 132 | N/A | N/A | N/A |
9/30/2017 | 1,190 | 134 | N/A | 38 | N/A |
6/30/2017 | 1,154 | 123 | N/A | N/A | N/A |
3/31/2017 | 1,135 | 112 | N/A | 85 | N/A |
12/31/2016 | 1,106 | 113 | N/A | N/A | N/A |
9/30/2016 | 1,088 | 98 | N/A | 112 | N/A |
6/30/2016 | 1,090 | 78 | N/A | 132 | N/A |
3/31/2016 | 1,083 | 80 | N/A | 96 | N/A |
12/31/2015 | 1,062 | 61 | N/A | 73 | N/A |
9/30/2015 | 1,040 | 62 | N/A | 57 | N/A |
6/30/2015 | 984 | 70 | N/A | 34 | N/A |
3/31/2015 | 946 | 66 | N/A | 44 | N/A |
12/31/2014 | 938 | 73 | N/A | 60 | N/A |
9/30/2014 | 909 | 75 | N/A | 63 | N/A |
6/30/2014 | 931 | 83 | N/A | 74 | N/A |
3/31/2014 | 924 | 89 | N/A | 69 | N/A |
12/31/2013 | 900 | 89 | N/A | 52 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0DHC's forecast earnings growth (16.3% per year) is above the savings rate (2.1%).
Earnings vs Market: 0DHC's earnings (16.3% per year) are forecast to grow faster than the UK market (14.7% per year).
High Growth Earnings: 0DHC's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0DHC's revenue (7.9% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0DHC's revenue (7.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0DHC's Return on Equity is forecast to be low in 3 years time (11.9%).